Summary
Background: End-stage heart failure treatment remains the field of transplant surgery. Despite tremendous results and steadily increasing quality of life and survival, the lack of donor organs and their increasing shortage over the last few years is relativizing the efforts made for the patients.
Methods and Results: A lot of projects for alternatives, originating from bridging methods, are under investigation and in progress. Besides different mechanical support devices (left-ventricular assist devices) there are also electrical (implantable cardioverter defibrillators, multisite) and biomechanical devices (cardiomyoplasty) offered. Furthermore, ventricular geometry shaping is a form of support (Batista, Acorn).
Conclusions: Really new and exciting approaches are on the surgical horizon with cellular cardiomyoplasty (stem-cell transplantation, foetal cardiomyocytes, skeletal myocyte transplantation, cytokine stimulation for immigration of stem cells to the heart).
Zusammenfassung
Grundlagen: Die Behandlung des Endstadiums einer Herzerkrankung bleibt im chirurgischen Bereich das Feld der Transplantation. Trotz großartiger Erfolge und ständig steigender Lebensqualität von Transplantierten mit gleichzeitig immer besserem Überleben, ist der Mangel an Spenderorganen während der letzten Jahre der relativierende Faktor.
Methodik und Ergebnisse: Daher gibt es eine Reihe von Alternativen und Projekten, die aus der Vergangenheit, aus den Bridging-Methoden zur Transplantation entstanden und derzeit in Entwicklung sind. Neben verschiedenen mechanischen Unterstützungspumpen (LVAD) gibt es auch elektrische (ICD, Multisite) und biomechanische Möglichkeiten (Kardiomyoplastie). Darüber hinaus wird auch die Modellierung der Ventrikelgeometrie als eine Form der Unterstützung (Batista, Acorn) untersucht.
Schlußfolgerungen: Wirklich neue und aufregende Ansätze gibt es im Bereich der zullulären Cardiomyoplastie (Stammzelltransplantation, fetale Kardiomyozyten, Skelettmuskeltransplantation und Zytokinstimulation zum Einwandern von Stammzellen in das Herz).
Similar content being viewed by others
References
Acker MA: Dynamic cardiomyoplasty: at the crossroads. Ann Thorac Surg 1999;68:750–755.
American Heart Association: Heart and stroke statistical update. Dallas 2000, 2001.
Anversa P: Myocyte death in the pathological heart. Circ Res 2000,86:121–124.
Anversa P, Kajstura J: Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 1998;83:1–14.
Asahara T, Murohara T, Sullivan A: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964–967.
Batista RJV, Verde J, Nery P, Bocchino L, Takeshita N, Bhayana JN, Bergsland J, Graham S, Houck JP, Salerno TA: Partial left ventriculectomy to treat end-stage heart disease. Ann Thorac Surg 1997;64:634–638.
Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P: Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344:1750–1757.
Bigger JT, Fleiss JL, Kleiger L, Miller JP, Rolnitzky LP and the Multicenter Postinfarction Research Group: The relationship among ventricular arrhythmias, left ventricular dysfunction and mortality in the 2 years after myocardial infarction. Am J Cardiol 1986;69:250–258.
Boersma H, Doornhos G, Bloemberg BPM, Wood DA, Kromhout D, Simoons ML: Cardiovascular disease in Europe. European Registries of Cardiovascular Diseases and Patient Management. Sophie-Antipolis, European Society of Cardiology, 1999, pp 26–27.
Boriani G, Biffi M, Martignani C, Gallina M and Brazi A: Cost-effectiveness of implantable cardioverter-defibrillators, Clinical Perspective. Eur Heart J 2001;33:990–996.
Bulkley BH: The cardiomyopathies. Hosp Pract (Off Ed) 1984;19:59–73.
Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G: A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882–1890.
Cardinal DS, Connelly DT, Steinhaus DM, Lemery R, Waters M, Foley L: Cost savings with nonthoracotomy implantable cardioverter-defibrillators. Am J Cardiol 1996;78:1255–1259.
Chachques JC, Argyriadis PG, Latremouille C, D’Attellis N, Fornes P, Bruneval P, Couetil JP, Carpentier AF: Cardiomyoplasty: Ventricular reconstruction after tumor resection. J Thorac Cardiovasc Surg 2002;123:889–894.
Chachques JC, Grandjean P, Schwartz K, Mihaileanu S, Fardeau M, Swynghedauw B, Fontaliran F, Romero N, Wisnewsky C, Perier P: Effect of latissimus dorsi dynamic cardiomyoplasty on ventricular function. Circulation 1988;78(Suppl):203–216.
Chinchoy E, Hill MR, Fisher W, Smith AL, Delurgio DB, Loh E, Kocovic DZ, Plapert T, Sutton MJ: Synchronous biventricular pacing improves myocardial performance index in heat failure patients with conduction abnormalities: Results from the miracle trial. Am Heart 2001;104:Abstract 2920.
Chiu RC-J, Zibaitis A, Kao RL: Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 1995;60:12–18.
DeRose JJ Jr, Umana JP, Argenziano M, Catanese KA, Gardocki MT, Flannery M, Levin HR, Sun BC, Rose EA, Oz MC: Implantable left ventricular assist devices provide and excellent outpatient bridge to transplantation and recovery. J Am Coll Cardiol 1997;30:1773–1777.
Domanski MJ, Zipes DP, Schron E: Treatment of sudden cardiac death. Circulation 1997;95:2694–2699.
Ector H: Pacemakers and ICD’s in Europe: results of the registry of the European Working Group on Cardiac pacing. G Ital Cardiol 1998;28(Suppl 1):176–184.
Ector H, Rickards F, Kappenberger L: The registry of the European Working Group on Cardiac Pacing (Abstr). PACE 1999;22(part II):782.
Ector H, Rickards F, Vardas P, Santini M, Sutton R, Kappenberger L: The registry of the European Working Group on Cardiac Pacing (Abstr). PACE 1998;21 (part II):960.
Franco-Cereceda A, McCarthy PM, Blacksonte EH, Hoercher KJ, White JA, Young JB, Starling RC: Partial left ventriculectomy for dilated cardiomyopathy: is this an alternative to transplantation? J Thorac Cardiovasc Surg 2001;121:879–893.
Friedman PL, Stevenson WG: Unsustained ventricular tachycardia. To treat or not to treat? N Engl J Med 1996;335:1984–1985.
Goldberg RJ, Gore JM, Alpert JS, Osganian V, de Groot J, Bade J, Chen Z, Frid D, Dalen JE: Cardiogenic shock after acute myocardial infarction: incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med 1991;325:1117–1122.
Gunnar RM, Passamani ER, Bourdillon PD, Pitt B, Dixon DW, Rapaport E, Fuster V, Reeves TJ, Karp RB, Russell RO Jr: Guidelines for the early management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association as Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. J Am Coll Cardiol 1990;16:249–223.
Hanashiro PK, Weil WH: Reliability of central venous pressure as a measure of changes in left-sided intra-cardiac pressures. Chest 1972;62:479–483.
Higgins SL: Impact of the multicenter Automatic Defibrillator implantation trial on implantable cardioverter defibrillator indication trends. Am J Cardiol 1999;83:79–82.
Hillebrands JL, Klatter FA, van den Hurk BMH, Popa ER, Nieuwendhuis P, Rozing J: Origin of neointimal endothelium and α-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 2001;1071:411–422.
Hunt SA, Frazier OH: Mechanical circulatory support and cardiac transplantation. Circulation 1998;97:2079–2090.
ISHLT transplant registry quarterly reports. Addision, TX, International Society for Heart and Lung Transplantation, 2001.
Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK, Goodell MA: Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001;107:1395–1402.
Johnson RA, Palacios I: Dilated cardiomyopathies of the adult. N Engl J Med 1982;307:1051–1058.
Kannel WB: Epidemiological aspects of Heart failure. Cardiol Clin 1989;7:1–9.
Kim EJ, Li RK, Weisel RD, Mickle DAG, Jia ZQ, Tomita S, Sakai T, Yau TM: Angiogenesis by endothelial cell transplantation. J Thorac Cardiovasc Surg 2001;122:963–971.
Koh GY, Soonpa MH, Klug MG, Field LJ: Long-term survival of AT1 cardiomyocyte grafts in syngeneic myocardium. Am J Physiol 1993;264:272–233.
Kumpati GS, McCarthy PM, Hoercher KJ: Surgical treatments for heart failure. Cardiol Clin 2001;19:669–681.
Kupersmith J: Cost-effective strategies in cardiology. In: Hurst JW et al. The Heart. Arteries and Veins. 9th edn. New York, McGraw Hill, 1998, pp 2557–2578.
Kupersmith J, Hogan A, Guerrero P, Gardiner J, Mellits ED, Baumgardner R, Rovner D, Holmes-Rovner M, McLane A, Levine J: Evaluating and improving the cost-effectiveness of the implantable cardioverter-defibrillator. Am Heart J 1995;130:507–515.
Kupersmith J, Homes-Rovner M, Rovner D, Gardiner J: Cost-effectiveness analysis in heart disease. Part II. Preventive therapies. Prog Cardiovasc Dis 1995;37:243–271.
Kupersmith J, Homes-Rovner M, Rovner D, Gardiner J: Cost-effectiveness analysis in heart disease. Part III. Ischemia congestive heart failure and arrhythmias. Prog Cardiovasc Dis 1995;37:307–346.
Kuppermann M, Luce BR, McGovern B, Bodrid PJ, Bigger JT, Ruskin JN: An analysis of the cost effectiveness of the implantable defibrillator. Circulation 1990;81:91–100.
Larsen GC, Manolis AS, Sonnenberg FA, Beshanski JR, Estes MNA, Pauker SG: Cost-effectiveness of the implantable cardoverter defibrillator effect of improved battery life and comparison with amiodarone therapy. J Am Coll Cardiol 1992;19:1323–1334.
Larsen GC, McAnulty JH, Hallstrom A: Hospitalization charges in the anti-arrhythmics versus implantable defibrillators (AVID) trial, the AVID economic analysis study (Abstr). Circulation 1997;96(Suppl):1–77.
Leor L, Patterson M, Quinones MJ, Kedes LH, Kloner RK: Transplantation of fetal myocardial tissue into the infarcted myocardium of rat: a potential method for repair of infarcted myocardium? Circulation 1996;78:283–238.
Leor J, Patterson M, Quinones MJ, Kedes LH, Kloner RA: Transplantation of fetal myocardial tissue into the infarcted myocardium of rat: a potential method for repair of infarcted myocardium? Circulation 1996;94(Suppl):332–336.
Li RK, Jia ZQ, Weisel RD, Merante F, Mickle DA: Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J Mol Cell Cardiol 1999;31:513–522.
Li RK, Jia ZQ, Weisel RD, Weisel RD, Mickle DA, Zhang J, Mohabeer MK, Rao V, Ivanov J: Cardiomyocyte transplantation improves heart function. Ann Thorac Surg 1996;62:654–661.
Li RK, Mickle DAG, Weisel RD, Mohabeer MK, Zhang J, Rao V: Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial tissue. Circulation 1997;96(Suppl):179–187.
Li RK, Mickle DAG, Weisel RD, Rao V, Jia ZQ: Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann Thorac Surg 2001;72:1957–1963.
Li RK, Mickle DAG, Weisel RD, Zhang J, Mohabeer MK: In vivo survival and function of transplanted rat cardiomyocytes. Circ Res 1996,78:283–288.
Maggioni AP, Zanetti G, Franzosi MG, Rovelli F, Santoro E, Staszewsky L, Tavazzi L, Tognoni G: Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: GISSI-2 results. Circulation 1993,87:312–322.
Magovern CJ, Mack CA, Zhang J, Rosengart TK, Isom OW, Crystal RG: Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor. Hum Gene Ther 1997;8:215–227.
Mancini DM, Beniaminowitz A, Levin H, Catanese K, Flannery M, DiTullio M, Savin S, Cordisco ME, Rose E, Oz M: Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 1998;98:2383–2389.
Marchlinski F, Buxton A, Waxmann H, Josephson ME: Identifying patients at risk of sudden death after myocardial infarction. Am J Cardiol 1983;52:1190–1196.
McCarthy PM, Starling RC, Young JB, Smedira NG, Goormastic M, Buda T: Left ventricular reduction surgery with mitral valve repair. J Heart Lung Transplant 2000;19(Suppl):64–67.
Menasché P, Hagege AA, Scorsin M, Pouzet B, Desnos M, Duboc D: Myoblast transplantation for heart failure. Lancet 2001;357:279–280.
Moreira LF, Stolf NA: Dynamic cardiomyoplasty as a therapeutic alternative: current status. Heart Fail Rev 2001;6:201–212.
Moss AJ, Hall J, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M: Improved survival with an implantable defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933–1940.
Mushlin AI, Hall J, Zwanziger J, Gajary E, Andrews M, Marron R, Zou KH, Moss AJ: The cost-effectiveness of implantable cardiac defibrillators: results from MADIT. Multcentre Automatic Defibrillator Trial. Circulation 1998;97:2129–2135.
Myerburg RJ, Interian A, Mitrani RM, Kessler KM, Castellanos A: Frequency of sudden cardiac death and profiles at risk. Am J Cardiol 1997;80(Suppl): 10–19.
O’Connell JB, Birstow MR: Economic impact of heart failure in the United States, time for a different approach. J Heart Lung Transplant 1994;13:107–112.
Orlic D, Cirard LJ, Anderson SM, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P: Indentification of human and mouse hematopoietic stem cell populations expressing high levels of mRNA encoding retrovirus receptors. Blood 1998;91:3247–3254.
Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P: Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701–705.
Owens DK, Sanders GD, Harris RA, McDonald KM, Heidenreich PA, Dembitzer AD, Hlatky MA: Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med 1997;126:1–12.
Pappone C, Vicedomini G, Nardi S, Tocchi M, Mazzone P, Gulletta S, Gioia CD, Candia CD, Salvati A, Rosanio S: Correction of left ventricular contractile asynchrony by biventricular pacing correlates with long-term outcome in patients with dilated cardiomyopathy. AHA 2001;104:abstract 2923.
Quaini F, Cigola E, Largrasta C, Saccani G, Quaini E, Rossi C, Olivetti G, Anversa P: End-stage cardiac failure in humans is complete with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. Circ Res 1994;75:1050–1063.
Quaini F, Urbanek K, Beltrami AP, Nadal-Ginard B, Kajstura J, Leri A, Anversa P: Chimerism of the transplanted heart. N Engl J Med 2002;346:5–15.
Rehak PH, Tscheliessnigg KH, Pierer G, Terpstra BJ: Cardiomyoplastie — Technik und erste tierexperimentelle Ergebnisse. Biomed Techn 1990;35:55–56.
Reida M, Ooi OC, Bongso A, Yacoub MH: Myocyte transplantation for myocardial repair: a few good cells can mend a broken heart. Ann Thorac Surg 2001;71:1724–1733.
Rigatelli GL, Carraro U, Barbiero M, Zanchetta M, Rigatelli G: New hopes for dynamic cardiomyoplasty from use of Doppler flow wire in evaluation of demand stimulation. J Cardiovasc Surg (Torino) 2002;43:67–70.
Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier PM, for the Randomized Evaluation of Mechanical Assistance for the Therapy of Congestive Heart Failure (REMATCH) Study Group: Long-term use of the left ventricular assist device for endstage heart failure. N Engl J Med 2001;345:1435–1443.
Rose EA, Moskowitz AJ, Packer M, Sollano JA, Williams DL, Tierney AR, Heitjan DF, Meier P, Ascheim DD, Levitan RG, Weinberg AD, Stevenson LW, Shapiro PA, Lazar RM, Watson JT, Goldstein DJ, Gelijns AC: The REMATCH trial: rationale, design, and end points: Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg 1999;67:723–730.
Saiura A, Sata M, Hirata Y, Nagai R, Makuuchi M: Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med 2001;7:382–383.
Saksena S, Madan N, Lewis C: Implanted cardioverter defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias. Prog Cardiovasc Dis 1996;38:445–454.
Sharon A, Hunt X: Comment — the REMATCH trial: long-term use of a left ventricular assist device for end-stage heart failure. J Card Failure 2002;8:2.
Starling RC, Young JB: Surgical therapy for dilated cardiomyopathy. Cardiol Clin 1998;Nov;16(4);727–737.
Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M: Cell migration, chimerism, and graft acceptance. Lancet 1992;339:1579–1582.
Stevenson LW, Kormos RL, Bourge RC, Gelijns A, Griffith BP, Hershberger RE, Hunt S, Kirklin J, Miller LW, Pae WE Jr, Pantalos G, Pennington DG, Rose EA, Watson JT, Willerson JT, Young JB, Barr ML, Costanzo MR, Desvigne-Nickens P, Feldman AM, Frazier OH, Friedman L, Hill JD, Konstam MA, McCarthy PM, Michler RE, Oz MC, Rosengard BR, Sapirstein W, Shanker R, Smith CR, Starling RC, Taylor DO, Wichman A: Mechanical cardiac support 2000: current applications and future trial design. J Am Coll Cardiol 2001;37:340–370.
Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, Kraus WE: Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998;4:929–933.
The artificial heart program: current status and history. In: Hoggness JR, VanAntwerp M (eds): The artificial heart: prototypes, policies, and patients. Washington, DC, National Academy Press, 1991, pp 14–25.
The CONSENSUS Trial Study Group: Effects of Enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429–1435.
The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293–302.
The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685–691.
Wever EF, Hauer RNW, Schrijvers G, van Capelle FJ, Tijssen JG, Crijns HJ, Algra A, Ramanna H, Bakker PF, Robles de Medina EO: Cost-effectiveness of implantable cardioverter defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in post infarct sudden death survivors. Circulation 1996;93:489–496.
Wilber DJ, Koll JG, Kapp DE: What can we expect from prophylactic implantable cardioverter defibrillators? Am J Cardiol 1997;80(Suppl):20–27.
Yamashita J, Ito H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M, Nakao K, Nishikawa S: Flk 1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000;408:92–96.
Yanagisawa-Miwa S, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T: Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992;257:1401–1403.
Zoni Berisso M, Silvestri D: Risk stratification after myocardial infarction: what is the clinical usefulness of programmed ventricular stimulation? In: Ravicle A (ed.): Cardiac arrhythmias. Milano, Springer Verlag, 1997, pp 213–221.
Zwiebel JA, Freeman SM, Kantoff PW, Cornetta K, Ryan US, Anderson WF: High-level recombinant gene expression in rabbit endothelials cells transduced by retroviral vectors. Science 1989;243:220–229.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tscheliessnigg, K.H. Surgical treatment of heart failure — A changing paradigm?. Eur. Surg. 34, 347–353 (2002). https://doi.org/10.1046/j.1563-2563.2002.02083.x
Issue Date:
DOI: https://doi.org/10.1046/j.1563-2563.2002.02083.x